Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mast cell secretory machinery is a complex protein system responsible for the regulated exocytosis of inflammatory mediators from mast cell granules. This machinery primarily consists of the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment protein REceptor) complex, including proteins such as SNAP-23, Syntaxin-4, and VAMP-8, along with regulatory proteins like Munc18-2, synaptotagmins, and Rab GTPases (Source: NIH, Frontiers in Immunology). Upon activation of mast cells, typically via IgE-FcεRI cross-linking, these proteins coordinate the docking and fusion of secretory granules with the plasma membrane, leading to the rapid release of histamine, proteases, and cytokines (Source: ResearchGate). Dysregulation of this process is central to the pathogenesis of allergic diseases, including asthma, allergic rhinitis, and anaphylaxis (Source: MDPI). Therapeutic agents known as mast cell stabilizers, such as cromolyn sodium and nedocromil, target this machinery to prevent degranulation and the subsequent inflammatory cascade (Source: Wikipedia, Drugs.com). These drugs are thought to act by stabilizing the cell membrane or blocking essential calcium channels, though the precise molecular interactions are still being elucidated (Source: StatPearls). Emerging research also explores the use of inhibitory peptides and siRNA to specifically disrupt SNARE complex formation as a novel approach to treating mast cell-mediated disorders (Source: PubMed).
Inhibition of mast cell degranulation by stabilizing the cell membrane and preventing the fusion of secretory granules with the plasma membrane; this may involve blocking calcium influx, modulating G protein-coupled receptors like GPR35, or directly interfering with SNARE complex assembly (Source: NIH, PubMed).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mast cell secretory machinery.